Archives

Heidelberg, Germany – Sep 19, 2018 – Novaliq will present at the upcoming Ophthalmology Futures Forums in Vienna. The Ophthalmology Futures Forums were established in 2012 to fill a void with [...]

Using innovative new technology, NovaTears® effectively establishes a new class of treatment for Evaporative Dry Eye. Free from preservatives, water and phosphates, and can be used for up to six [...]

Heidelberg, Germany – April 24, 2018 – Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics [...]

Heidelberg, Germany – January 8, 2018 – Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics [...]

Heidelberg, Germany – January 8, 2018 – Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics [...]

Heidelberg, Germany – December 6, 2017 – Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics [...]

Heidelberg, Germany – November 9, 2017 – Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics [...]

Heidelberg, Germany – October 30, 2017 – Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics [...]

Heidelberg, Germany – October 2, 2017 – The German Ophthalmological Society (DOG) presented Uta Gehlsen, PhD, Ocular Surface Group, Department of Ophthalmology, University of Cologne, with the [...]

July 11, 2017 – NOVALIQ GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, today [...]